Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Perego Kenneth II

(Last)

(First)

(Middle)

6605 GRAND MONTECITO PKWY., SUITE 100

(Street)

LAS VEGAS

NV

89149

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
One World Products, Inc. [ OWPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/25/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								7,000,000	I	See footnote⁽⁵⁾
Common Stock								5,785,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A Preferred Stock	⁽¹⁾	07/25/2024		A		15,000		07/25/2024	⁽¹⁾	Common Stock	1,500,000	$150,000⁽¹⁾⁽²⁾⁽⁶⁾	2,600,000⁽⁷⁾	I	See footnote⁽⁴⁾
Warrants to Purchase Common Stock	$0.25	07/25/2024		A		1,500,000		07/25/2024	07/25/2029	Common Stock	1,500,000	$0.00⁽¹⁾⁽³⁾⁽⁶⁾	2,050,000	I	See footnote⁽⁴⁾

Explanation of Responses:

1. 15,000 shares of Series A Preferred Stock and a Warrant to Purchase Common Stock of the Issuer were purchased, in units, by the Reporting Person for $150,000 in cash. Each share of Series A Preferred Stock is convertible at any time, at the Reporting Person's election, into 100 shares of the Issuer's common stock and has no expiration date

2. Each share of Series A Preferred Stock is convertible at any time, at the election of the Reporting Person, into 100 shares of common stock of the Issuer.

3. The Warrant to Purchase Common Stock is exercisable at any time, at the election of the Reporting Person, at an exercise price of $0.25 per share.

4. Owned of record by Perego Trust, of which the Reporting Person is Trustee.

5. Owned of record by CB Medical, LLC, of which the Reporting Person is the owner.

6. All of the purchase price was allocated to the shares of Series A Preferred Stock.

7. The Reporting Person beneficially owns a total of 17,785,000 shares of common stock of the Issuer.

Remarks:

This is a late Form 4 filing.

	/s/ Dr. Kenneth Perego, II, M.D.	08/22/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.